Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
Guozhen Yang(State Key Laboratory of Oncology in South China), Xu Zhang(Affiliated Hospital of Hebei University), Chunhua Qu(Sun Yat-sen University Cancer Center), Ting Bei(Hua Medicine (China)), Yi Hu(Army Medical University), Yuanheng Huang(Sun Yat-sen University), Peiqiang Cai(State Key Laboratory of Oncology in South China), Qianwen Liu(Sun Yat-sen University), Yuezong Bai(Hua Medicine (China)), Jiudi Zhong(Sun Yat-sen University), Mengli Huang(Sun Yat-sen University), Wenzhuan Xie, Haoqiang He(Sun Yat-sen University Cancer Center), Yijun Zhang(State Key Laboratory of Oncology in South China), Zhi‐Qiang Wang(Nanjing University of Chinese Medicine), Jianhua Fu(Hefei University of Technology), Qiyu Guo(Sun Yat-sen University), Jin Xiang(Wuhan University), Xiaodong Su(Sun Yat-sen University), Chan Gao(Zhejiang Chinese Medical University), Yating Zheng, Hong Yang(Sun Yat-sen University), Guangyu Luo(Sun Yat-sen University), Muyan Cai(Sun Yat-sen University)
Cited by 54
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
Dishevelled: The hub of Wnt signaling
|Cellular Signalling|2009|751
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation
|Nature Cell Biology|2010|395
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
|Journal of Hepatology|2021|245